Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

163.32
BATS BZX Real-Time Price
As of 1:27pm ET
 -3.39 / -2.03%
Today’s Change
128.87
Today|||52-Week Range
172.20
+5.99%
Year-to-Date
Becton Dickinson: 19% EPS Growth With Good Dividends
Jun 26 / GuruFocus News - Paid Partner Content
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Jun 13 / Zacks.com - Paid Partner Content
Strong And Under The Radar: Becton Dickinson (BDX)
Jun 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close166.71
Today’s open166.49
Day’s range162.57 - 166.64
Volume43,164
Average volume (3 months)958,778
Market cap$35.4B
Dividend yield1.62%
Data as of 1:27pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.67%
Earnings growth (next 5 years)+11.25%
Revenue growth (last year)+21.94%
P/E ratio43.7
Price/Sales2.68
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.29-1.30%
SYKStryker Corp-1.40-1.20%
ZBHZimmer Biomet Holdin...-1.15-0.99%
EWEdwards Lifesciences...-1.05-1.09%
Data as of 1:28pm ET, 06/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
Chief Financial Officer &
EVP-Administration
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Partner Offers

Search for Jobs